Astrazeneca ADR Stock
Price
Target price
€71.00
€71.00
-0.700%
-0.5
-0.700%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Astrazeneca ADR Stock
Astrazeneca ADR shows a slight decrease today, losing -€0.500 (-0.700%) compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Astrazeneca ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Astrazeneca ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | -0.700% | 3.623% | -10.063% | 10.853% | 16.260% | 38.566% | - |
| GSK plc ADR | -1.630% | 0.000% | -8.040% | 5.780% | 8.929% | -11.273% | -25.306% |
| Bayer AG ADR | - | 6.522% | 3.521% | -34.375% | -14.535% | -35.526% | -54.063% |
| Novo Nordisk A/S ADR | -0.470% | -4.889% | -15.079% | 24.130% | 14.072% | 29.227% | 130.603% |
News
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Investors looking for stocks that can reliably outperform the broad market should have a look at the pharmaceutical industry. The tailwind pushing them forward is powerful. In the U.S., around
3 Market-Beating Stocks to Buy for Less Than $100
You don't have to look at top tech stocks to find good investments to buy and hold. There are many good stocks you can buy for less than $100 that are beating the market today and can continue to do
Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
In a market characterized by uncertainty and volatility, it's increasingly rare to find stocks that are weathering the storm and thriving. Yet, a select few from various sectors are doing just
